QUEENSLAND CIVIL AND
ADMINISTRATIVE TRIBUNAL
CITATION: Pharmacy Board of Australia v Amurao [2025] QCAT 100 PARTIES: PHARMACY BOARD OF AUSTRALIA
(applicant)v EDGARDO AMURAO
(respondent)APPLICATION NO/S: OCR264-22 MATTER TYPE: Occupational regulation matters DELIVERED ON: 15 April 2025 HEARING DATES: 9 and 10 October 2024 Written submissions filed by the applicant on 13
November 2024; and the respondent on 28 January 202514 March 2025 HEARD AT: Brisbane DECISION OF: Judicial Member Murphy SC
Assisted by:
Mrs K Thomson
Mr B Swan
Ms J FeeneyORDERS:
Pursuant to s 196(1)(b)(iii) of the National Law, the conduct of Edgardo Amurao as alleged in grounds 1 to 6 of the referral constitutes, when taken together, professional misconduct as defined by subparagraph (c) of the definition of that term in s 5 of the National Law.
Pursuant to s 196(2)(a) of the National Law, Edgardo Amurao is reprimanded.
Pursuant to s 196(2)(e) of the National Law, Edgardo Amurao’s registration is cancelled.
There be no order for costs.
CATCHWORDS:
PROFESSIONS AND TRADES – HEALTH CARE PROFESSIONALS – PHARMACEUTICAL CHEMISTS – DISCIPLINARY PROCEEDINGS – where the respondent practitioner engaged in conduct towards his female colleagues that made them feel uncomfortable – where the respondent practitioner unlawfully dispensed, or caused to be dispensed, medications to himself – where the respondent practitioner gave false or misleading information to the
applicant Board regarding the dispensing of medications – where the respondent practitioner’s conduct, when viewed together, constitutes professional misconduct – whether a period of disqualification should be imposed
Health Practitioner Regulation National Law
(Queensland)
Medicine and Poisons (Medicines) Regulation 2021 (Qld)
Poisons and Therapeutic Goods Regulation 2008 (NSW)
Queensland Civil and Administrative Tribunal Act 2009
(Qld)A Solicitor v Council of the Law Society of New South
Wales [2004] HCA 1; 216 CLR 253
Bonitto v Fuerst Bros & Co Limited [1944] AC 75
Fittock v Legal Profession Conduct Commission (No 2)
[2015] SASFC 167
Health Ombudsman v Kumar [2024] QCAT 132
LCK v Health Ombudsman (No 2) [2020] QCAT 460
Looke v Parbury Henty & Co Pty Ltd [1950] VLR 94
McBride v Walton [1994] NSWCA 199
Medical Board of Australia v TXA (No 2) [2023] QCAT
115
Medical Board of Australia v Wong [2015] QCAT 439
New South Wales Bar Association v Cummins [2001]
NSWCA 284
Nursing and Midwifery Board v Seijbel-Chocmingkwan
[2015] QCAT 283
Re Davis (1947) 47 CLR 409
Re Day [2017] HCA 2; 340 ALR 368
Re Moage Limited [1998] FCA 296; (1998) 153 ALR 711
R v Davison [2022] QCA 22
Trustees of the Property of Cummins v Cummins [2006]
HCA 6; 227 CLR 278
Zaidi v Health Care Complaints Commission (1998) 44
NSWLR 82
Ziems v The Prothonotary of the Supreme Court of NSW
(1957) 97 CLR 279APPEARANCES &
REPRESENTATION:Applicant: L Marshall instructed by Minter Ellison Respondent: Self-represented REASONS FOR DECISION
Edgardo Amurao obtained general registration as a pharmacist in February 2019. Between April of that year and November 2020, he was employed for varying periods…
Keep reading for free
Create a free CaseChat account to read Pharmacy Board of Australia v Amurao and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2025] QCAT 100
- Decision Date
CaseChat Overview and Summary
The central legal issues the AAT had to decide were whether Mr Amurao's conduct amounted to professional misconduct and, if so, what the appropriate disciplinary action should be. The AAT examined the nature and impact of Mr Amurao's conduct on his female colleagues, his unlawful dispensing of medications, and the veracity of his statements to the Board. The AAT considered the evidence presented by Mr Amurao and the complainants, including their personal accounts and cultural contexts, to assess the allegations.
The AAT found that Mr Amurao's conduct, when considered as a whole, constituted professional misconduct. The Tribunal was persuaded by the consistent evidence from the complainants that Mr Amurao's behaviour was persistent, unwanted, and made them feel unsettled and uncomfortable. The Tribunal also noted that Mr Amurao's self-representation and focus on peripheral issues during the proceedings did not effectively challenge the complainants' accounts. The AAT concluded that the cumulative effect of Mr Amurao's actions warranted a finding of professional misconduct.
The AAT ordered that the conduct of Mr Amurao, as alleged in the grounds of the referral, constituted professional misconduct under the National Law. This finding was based on the impact of his conduct on his colleagues and his unlawful dispensing of medications. The specific orders issued by the AAT were not detailed in the text provided, but typically, such findings would lead to disciplinary measures such as fines, suspension, or revocation of his practising certificate.
Orders
Orders of the court
Pursuant to s 196(1)(b)(iii) of the National Law, the conduct of Edgardo Amurao as alleged in grounds 1 to 6 of the referral constitutes, when taken together, professional misconduct as defined by subparagraph (c) of the definition of that term in s 5 of the National Law.
Background
Background to the litigation
Evidence
Evidence Before The Court
Decision
Reasons for decision
Ratio Decidendi